Please try another search
For the three months ended 31 March 2022, Sejong Medical Co Ltd revenues decreased 6% to W4.06B. Net loss totaled W789.2M vs. income of W130.4M. Revenues reflect Asia (Region) segment decrease of 40% to W375.7M, South Korea (Country) segment decrease of 4% to W3.27B. Net loss reflects Interest Expense increase from W50.4M to W913.9M (expense), Commission Paid increase of 42% to W1.03B (expense).
Period Ending: | Dec 31, 2023 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
---|---|---|---|---|
Total Revenue | 8146.03 | 0 | 4063.36 | |
Gross Profit | 4292.48 | 10.82 | 1746.82 | |
Operating Income | -1694.97 | 0 | -546.11 | |
Net Income | -1201.99 | 0.006 | -789.18 |
Period Ending: | Dec 31, 2023 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
---|---|---|---|---|
Total Assets | 121179.99 | 117905.02 | 113322.49 | 112050.72 |
Total Liabilities | 103902.07 | 56201.42 | 58644.87 | 57221.35 |
Total Equity | 17277.92 | 61703.59 | 54677.62 | 54829.37 |
Period Ending: | Dec 31, 2023 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -253.56 | 115.08 | 320.86 | |
Cash From Investing Activities | -14725.26 | 10412 | -19788.47 | |
Cash From Financing Activities | 4484.49 | -49.02 | 19581.6 | |
Net Change in Cash | -10448.5 | 10498.21 | 101.19 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review